Skip to content

Transversus Abdominis Plane (TAP) Block with or without intrathecal morphine for analgesia following lower segment Caesarean Section

Transversus Abdominis Plane (TAP) Block with or without intrathecal morphine for analgesia following lower segment Caesarean Section

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2007-000392-42-IE
Enrollment
80
Registered
2007-04-17
Start date
2007-06-14
Completion date
Unknown
Last updated
2025-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

This trial investigates four techniques for analgesia provision after Elective Lower Segment Caesarean Section

Interventions

Trade Name: Marcain Polyamp Pharmaceutical Form: Solution for injection Pharmaceutical form of the placebo: Injection* Route of administration of the placebo: Infiltration use

Sponsors

Department of Anaesthesia, Rotunda Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: American Society of Anesthesiologists Grade I and II patients presenting electively for first or second Lower Segment Caesarean Section. Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: Allergy to bupivacaine, use of antiarrhythmic drugs, contraindications to paracetamol or diclofenac administration, contraindication to central neuraxial blockade

Design outcomes

Primary

MeasureTime frame
Main Objective: To determine the regime of pain relief which produces the lowest pain scores and morphine requirements after Lower Segment Caesarean Section ;Secondary Objective: To determine which of the regimes cause the least nausea, vomiting and sedation and the highest level of patient satisfaction after Lower Segment Caesarean Section;Primary end point(s): Visual analogu pain scores and morphine use at 6, 12, 24 and 36 hours postoperatively

Countries

Ireland

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026